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Early Identiﬁcation and Monitoring Progression
of Chagas’ Cardiomyopathy With SPECT Myocardial
Perfusion Imaging*
Ronald G. Schwartz, MD, MS, FACC, FAHA, FASNC,
Orren Wexler, BS
Rochester, New YorkIn this issue of iJACC, Hiss et al. (1) report
correlations of single-photon emission computed
tomography (SPECT) perfusion defects with sub-
sequent left ventricular dysfunction by echocardiog-
raphy in patients with chronic Chagas’ cardiomy-
opathy. In 36 patients with a 5.6-year follow-up
period, the authors demonstrated a topographic
association between SPECT perfusion defects at
rest and subsequent development of regional left
See page 164
ventricular (LV) dysfunction. In the absence of
demonstrable coronary artery disease by coronary
angiography in these patients with Chagas’ disease,
stress perfusion defects by SPECT myocardial per-
fusion imaging (MPI) progressed to rest defects;
and this disease progression evidenced by SPECT
MPI was associated with a reduction in left ven-
tricular ejection fraction (LVEF) assessed by echo-
cardiography.
Chagas’ disease is a model of microvascular
dysfunction associated with perfusion abnormalities
assessed as reversible perfusion defects in the ab-
sence of angiographic disease (2,3). Of the 36
patients in the study by Hiss et al. (1), all 20
patients with reversible perfusion defects had nor-
mal subsequent angiograms. The cardiomyopathy
of Chagas’ disease is thought to result from para-
sitism of myocardial fibers by T. cruzi and inflam-
matory effects of an autoimmune reaction that sets
*Editorials published in JACC: Cardiovascular Imaging reflect the views of
the authors and do not necessarily represent the views of JACC: Cardio-
vascular Imaging or the American College of Cardiology.From the University of Rochester Medical Center, Rochester, New York.the stage for endothelial dysfunction, myocytolysis,
and myocardial fibrosis (4). Both human and ex-
perimental studies support the suggestion that de-
rangements of the coronary microcirculation are
associated with this process (2,4). Progression of
Chagas’ disease is associated with more marked
myocardial fibrosis, as demonstrated by cardiac
magnetic resonance imaging (5), and likely accounts
for the progression from vasodilator stress-induced
defects to resting perfusion defects seen in the
current observational study by Hiss et al. (1).
Camici and Crea (6) have provided an elegant
review of the spectrum of coronary microvascular
dysfunction in human diseases and suggest the
potential for risk stratification and tracking treat-
ment effectiveness by noninvasive assessment of
coronary flow reserve. Coronary flow reserve, as
well as its scintigraphic correlate myocardial perfu-
sion reserve, is the ratio of maximal to resting
coronary flow. Maximal flow is achieved with va-
sodilator stress interventions such as dipyridamole,
adenosine, and the selective A2a agonists (6). Dif-
ferences in coronary flow reserve in the absence of
epicardial stenosis are likely due to endothelial
dysfunction at the levels of the conduit arteries or
the coronary arterioles (microvasculature). Diffuse
arteriopathy and subtle reductions in luminal diam-
eter associated with atherosclerosis, coronary in-
flammation, myocardial inflammation, or myocar-
dial fibrosis as in Chagas’ disease might impact flow
reserve as well. The regional nature of Chagas’
disease likely facilitated detection of disease with
MPI on the basis of regional relative differences in
myocardial perfusion reserve. Whether quantifica-
tion of absolute flow by positron emission tomog-
raphy will further identify disease progression and
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174isk of events in Chagas’ disease remains open for
uture investigation.
The techniques and findings of this study
rovide remarkable insights regarding the role of
PECT MPI to identify both the early onset and
he progression of Chagas’ cardiomyopathy. The
light, statistically significant decline in LVEF by
chocardiography over 5 years from 55% to 50%
as not influenced by technical measurement
ffects of subendocardial hypoperfusion on vol-
me and EF calculations by electrocardiography
ECG)-gated radionuclide SPECT MPI. It can
e expected that LV volume indexes likely in-
reased as cardiomyopathy progressed, although
hese potent quantitative radionuclide prognostic
ndexes were not obtained in the current study,
ecause ECG-gating of the SPECT images was
ot performed. Deterioration of LVEF over time
nd increases in LV volume indexes imply worse
rognosis in cardiomyopathy, suggesting a poten-
ially important role of ECG-gated SPECT MPI
n providing greater risk stratification in Chagas’
ardiomyopathy. Thus, ECG-gated SPECT
PI seems well suited to track alterations of
yocardial perfusion, regional function, global
F, and volume indexes as mechanistic markers
hat correlate with the pathogenesis of myocar-
ial injury in the progression of Chagas’ cardio-
yopathy. Despite not reporting ECG-gated LV
olumes, this report by Hiss et al. (1) represents
he first longitudinal study to demonstrate the
orrelation between myocardial perfusion distur-
ances and progression of regional and global LV
ystolic dysfunction in chronic Chagas’ cardiomy-
pathy.
With this report by Hiss et al. (1), Chagas’
isease joins a growing list of conditions as reviewed
y Camici and Crea (6) that are associated with
yocardial perfusion abnormalities detectable in
he absence of angiographic coronary disease, such
s coronary risk factors, atherosclerosis, diabetes,
ypertension, hypertrophic cardiomyopathy, aortic
nd mitral valvular diseases, infiltrative diseases, and
igarette smoking (6). Endothelial dysfunction hasfunction in chronic Chagas’ cardiomy- Am J Cardiol 1992;6ardiovascular events (7–9) and is known to produce
egional differences in myocardial perfusion, as
videnced by SPECT and positron emission to-
ography imaging techniques. In the case of cor-
nary atherosclerosis, Schachinger et al. (8) have
emonstrated that impressive vasospasm with vaso-
otor stress with adenosine or other interventions
uring coronary angiography correlates with the
ite-specific development of subsequent stenosis an
verage of 3.7 years later and best identified patients
ho clinically progressed to experience clinical
vents. As reported by Hiss et al. (1) in the current
tudy of Chagas’ disease, abnormalities of endothe-
ial function imaged by stress SPECT imaging early
n the course of the disease seem to predict site-
pecific progression of defects at rest, reflecting
rogressive fibrosis, and regional systolic dysfunc-
ion preceding a decline in calculated LVEF.
In summary, this study is an important contribu-
ion to the published data that correlates serial
rogression of stress and rest perfusion defects by
PECT MPI and subsequent regional and global
V dysfunction with the suspected pathophysiolog-
cal progression of Chagas’ cardiomyopathy from
oronary microvascular dysfunction to fibrosis and
rank chamber dilation and dysfunction. Beyond
arly detection of Chagas’ disease, SPECT MPI
ffers promise to track subclinical progression of
hagas’ cardiomyopathy. This study by Hiss et al.
1) offers real hope that we have in SPECT MPI a
ool to identify early in Chagas’ disease the effec-
iveness of future therapies designed to prevent the
nsidious and inexorable progression of cardiomy-
pathy before onset of intense cardiac chamber
ilation, heart failure, malignant ventricular ar-
hythmia, and thromboembolic phenomena that
haracterize its devastating clinical course and
oorly understood pathogenesis.
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chwartz, University of Rochester Medical Center, Car-
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er, New York 14642-8679. E-mail: ronald_schwartz@emerged as a significant predictor of subsequent urmc.rochester.edu.3
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